Reduced Volumetric Bone Mineral Density of the Spine in Adolescent Rett Girls with Scoliosis.
Konstantinos TsaknakisJan H KreuzerFriederike Luise MetzgerKatharina Blanka JäckleKatja A LüdersLena BraunschweigHeiko M LorenzAnna Kathrin HellPublished in: Children (Basel, Switzerland) (2022)
In advanced Rett syndrome (RTT), limited or complete loss of ambulation, nutritional problems and scoliosis are unfavorable factors for bone mineral density (BMD). Still, there are few data available in this research area. Spinal quantitative computed tomography (QCT) allows an exact measurement of the volumetric BMD (vBMD) in this patient group. Two examiners measured vBMD of thoracic and lumbar vertebrae on asynchronous calibrated CTs that were acquired prior to surgical scoliosis correction (n = 21, age 13.6 ± 2.5 years). The values were compared to age- and sex-matched healthy controls to additionally derive Z-scores (n = 22, age 13.8 ± 2.0 years). The results showed the most significant reduction of vBMD values in non-ambulatory RTT patients, with p < 0.001 and average BMD-Z-score -1.5 ± 0.2. In the subgroup comparison, non-ambulatory patients with valproate treatment had significant lower values ( p < 0.001) than ambulatory patients without valproate therapy, with an average BMD-Z-score of -2.3 ± 0.2. Comparison of the Z-scores to critical BMD thresholds of 120 and 80 mg/cm 3 showed normal Z-scores in case of the ambulatory RTT subgroup, as opposed to BMD-Z-scores of the non-ambulatory RTT subgroups, which were partially below osteopenia-equivalent values. Furthermore, valproate treatment seems to have a direct effect on vBMD in RTT patients and when combined with loss of ambulation, BMD-Z-scores are reduced to osteoporosis-equivalent levels or even further.
Keyphrases
- bone mineral density
- postmenopausal women
- blood pressure
- body composition
- computed tomography
- end stage renal disease
- ejection fraction
- newly diagnosed
- mental health
- prognostic factors
- stem cells
- young adults
- case report
- randomized controlled trial
- magnetic resonance
- spinal cord injury
- high resolution
- minimally invasive
- mesenchymal stem cells
- mass spectrometry
- open label
- image quality